»
Medication for Opioid Use Disorder During Pregnancy — Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014–2021

Medication for Opioid Use Disorder During Pregnancy — Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014–2021

The article analyzes data from the MAT-LINK project (2014–2021), which tracks maternal and infant outcomes associated with medications for opioid use disorder (MOUD) during pregnancy. It emphasizes that MOUD improves maternal health but highlights the need for tailored care to address neonatal outcomes, including opioid withdrawal.

Miele, K., Kim, S. Y., Jones, R., Rembert, J. H., Wachman, E. M., Shrestha, H., Henninger, M. L., Kimes, T. M., Schneider, P. D., Sivaloganathan, V., Sward, K. A., Deshmukh, V. G., Sanjuan, P. M., Maxwell, J. R., Seligman, N. S., Caveglia, S., Louis, J. M., Wright, T., Bennett, C. C., Green, C., … Gilboa, S. M. (2023). Medication for Opioid Use Disorder During Pregnancy – Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021. Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002)72(3), 1–14. https://doi.org/10.15585/mmwr.ss7203a1